Screener
Neuropace, Inc. NPCE Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Neuropace, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Neuropace, Inc.’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:33 PM EDT
- Fiscal quarter
- Q4 FY2030
- Calendar quarter
- Q4 2030
- Accession
- 0001528287-26-000030
FAQ
- What is Neuropace, Inc.'s debt-to-equity?
- Neuropace, Inc. (NPCE) reported debt-to-equity of 5.9× in Q2 2026.
- How has Neuropace, Inc.'s debt-to-equity changed year-over-year?
- Neuropace, Inc.'s debt-to-equity increased by 59.9% year-over-year, from 3.7× to 5.9×.
- What is the long-term trend for Neuropace, Inc.'s debt-to-equity?
- Over 4 years (2021 to 2025), Neuropace, Inc.'s debt-to-equity has grown at a 47.8% compound annual growth rate (CAGR), from 0.8× to 3.7×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Neuropace, Inc.'s debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude